Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy

The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (<i>Id1</i>) and inhibitor of differentiation 3 <i>(Id3)</i> (referred to as <i>Id</i>) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Archana P. Thankamony, Reshma Murali, Nitheesh Karthikeyan, Binitha Anu Varghese, Wee S. Teo, Andrea McFarland, Daniel L. Roden, Holly Holliday, Christina Valbirk Konrad, Aurelie Cazet, Eoin Dodson, Jessica Yang, Laura A. Baker, Jason T. George, Herbert Levine, Mohit Kumar Jolly, Alexander Swarbrick, Radhika Nair
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI AG 2020-09-01
Серии:Biomolecules
Предметы:
cancer stem cells
chemoresistance
self-renewal
combination therapy
<i>Id1</i>
<i>Kif11</i>
Online-ссылка:https://www.mdpi.com/2218-273X/10/9/1295
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы